Laurus Labs Limited
LAURUSLABS
Peringkat dalam Saham
#1751
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Harga Saham
$22.85
Kapitalisasi Pasar
$12.34B
Perubahan (1 hari)
0.56%
Perubahan (1 tahun)
123.43%
Negara
IN
Perdagangan Laurus Labs Limited (LAURUSLABS)
Kategori
Healthcare
Margin Operasi untuk Laurus Labs Limited (LAURUSLABS)
Margin Operasi per October 2026 TTM: 21.28%
Menurut laporan keuangan dan harga saham terbaru dari Laurus Labs Limited, margin operasi saat ini (TTM) adalah 21.28%. Pada akhir 2024, margin operasi perusahaan adalah 35.80%.
Riwayat margin operasi untuk Laurus Labs Limited dari 2013 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Mengubah |
|---|---|---|
| 2026 (TTM) | 21.28% | -45.62% |
| 2025 | 39.13% | 9.30% |
| 2024 | 35.80% | 67.06% |
| 2023 | 21.43% | -11.85% |
| 2022 | 24.31% | -15.00% |
| 2021 | 28.60% | 105.90% |
| 2020 | 13.89% | 44.84% |
| 2019 | 9.59% | -34.49% |
| 2018 | 14.64% | -10.79% |
| 2017 | 16.41% | 1.99% |
| 2016 | 16.09% | 50.23% |
| 2015 | 10.71% | -29.82% |
| 2014 | 15.26% | -10.18% |
| 2013 | 16.99% | 0.00% |
Margin Operasi untuk perusahaan sejenis atau pesaing
| Perusahaan | Margin Operasi | Perbedaan Margin Operasi | Negara |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -98.92% |
IN
|
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.